New York City (AFP) - Teva Pharmaceutical Industries, the world's largest maker of generic drugs, announced Wednesday the departure of its chief executive Jeremy Levin.
Levin is leaving immediately after spending less than two years on the job with the Israeli company, it said in a statement without giving a reason for his departure.
The news came a day before the company is to announce its third-quarter earnings. It is listed on the New York Stock Exchange.
Teva announced earlier this month it will slash its global workforce by 10 percent by the end of 2014 as part of a mammoth cost-cutting plan.
About 5,000 jobs are to be eliminated, out of a global workforce of 46,000.
Levin, who is a doctor by trade, took over as CEO of Teva in May 2012.
He will be replaced temporarily by chief financial officer Eyal Desheh while Teva seeks a new CEO.